In Vivo Imaging and Quantitation of the Host Angiogenic Response in Zebrafish Tumor Xenografts
6,973 Views
•
11:07 min
•
August 14, 2019
DOI:
Summary
Automatically generated
El objetivo de este método es generar un modelo in vivo de angiogénesis tumoral mediante células tumorales de mamíferos xenografting en un embrión de pez cebra que tiene vasos sanguíneos marcados fluorescentemente. Mediante la toma de imágenes del xenoinjerto y los vasos asociados, se puede obtener una medición cuantitativa de la respuesta angiogénica.
Videos relacionados
07:31
Testing the Vascular Invasive Ability of Cancer Cells in Zebrafish (Danio Rerio)
Videos relacionados
12022 Views
09:22
Invasive Behavior of Human Breast Cancer Cells in Embryonic Zebrafish
Videos relacionados
16657 Views
09:43
Transplantation of Zebrafish Pediatric Brain Tumors into Immune-competent Hosts for Long-term Study of Tumor Cell Behavior and Drug Response
Videos relacionados
11520 Views
09:50
Drug Screening of Primary Patient Derived Tumor Xenografts in Zebrafish
Videos relacionados
7997 Views
06:46
Ortho- and Ectopic Zebrafish Xeno-Engraftment of Ocular Melanoma to Recapitulate Primary Tumor and Experimental Metastasis Development
Videos relacionados
1392 Views
12:08
Generation of Zebrafish Larval Xenografts and Tumor Behavior Analysis
Videos relacionados
11939 Views
06:10
A Simple, Rapid, and Effective Method for Tumor Xenotransplantation Analysis in Transparent Zebrafish Embryos
Videos relacionados
1251 Views
11:07
In Vivo Imaging and Quantitation of the Host Angiogenic Response in Zebrafish Tumor Xenografts
Videos relacionados
7.0K Views
12:08
Generation of Zebrafish Larval Xenografts and Tumor Behavior Analysis
Videos relacionados
11.9K Views
09:50
Drug Screening of Primary Patient Derived Tumor Xenografts in Zebrafish
Videos relacionados
8.0K Views
Read Article
Cite this Article
Britto, D. D., Hall, C. J., Astin, J. W. In Vivo Imaging and Quantitation of the Host Angiogenic Response in Zebrafish Tumor Xenografts. J. Vis. Exp. (150), e59849, doi:10.3791/59849 (2019).
Copy